Tweet Content
vit D shows no change in Fx Risk. Study of 20,326 Australians given placebo or vit D3 60K IU/mo. 46% women, age 69 yrs. W/ 5.1 yrs F/U - no effect on Fx risk (HR 0·94; 0·84–1·06). Fx in 5.6% of Vit D vs 5.9% in PBO (non-vertebral, major OP & hip Fxs https://t.co/cSbTS3xWrX https://t.co/Jipzw28Wn8
Links
Antiphospholipid Antibodies With Incident Cardiovascular Events Are antiphospholipid antibodies (aPL) associated with
Tweet Content
Antiphospholipid Antibodies With Incident Cardiovascular Events
Are antiphospholipid antibodies (aPL) associated with atherosclerotic cardiovascular (ASCVD) event risk?
https://t.co/XQk17P6D2f https://t.co/y5exrsicW8
Links
RheumThoughts: Changing the Conversation with Patients: Lupus Join the discussion! RheumThoughts are opinion pieces fr
Tweet Content
RheumThoughts: Changing the Conversation with Patients: Lupus
Join the discussion! RheumThoughts are opinion pieces from healthcare professionals.
https://t.co/NcJcCZVlbE
@drbags71 https://t.co/VfAqUkqLak
Links
RheumNow Presents Women In Rheumatology: Contract Negotiations https://t.co/nkAu5kQj2w
Tweet Content
RheumNow Presents Women In Rheumatology: Contract Negotiations https://t.co/nkAu5kQj2w
TONIGHT! Tuesday Night Rheumatology addresses Contract Negotiations, featuring Andrea Liberatore, JD, Gwenesta Melton, M
Tweet Content
TONIGHT! Tuesday Night Rheumatology addresses Contract Negotiations, featuring Andrea Liberatore, JD, Gwenesta Melton, MD, and Kathryn Dao, MD.
Sign up to attend this and all of our Tuesday Night Rheumatology series.
@uptoTate @KDAO2011
https://t.co/L2WMLnnJhV https://t.co/Z4kEBJHBjz
Links
Probiotic strain Ligilactobacillus salivarius studied in gout (as it metabolizes purines). 30 pts w/ hyperuricemia &
Tweet Content
Probiotic strain Ligilactobacillus salivarius studied in gout (as it metabolizes purines). 30 pts w/ hyperuricemia & recurrent gout were given L. salivarius or allopurinol for 6 mos. Probiotic group had less gout attacks (5/15) than controls (13/15). https://t.co/njPZdKhBxv https://t.co/YO27M8p5Ki
Links
April's Therapeutic Update focuses on gender differences in disease states and therapeutic outcomes. Sex Differences in
Tweet Content
April's Therapeutic Update focuses on gender differences in disease states and therapeutic outcomes. Sex Differences in axSpA and PsA, Gender Differences in Vasculitis, and Gender Differences in Counseling Patients on Reproductive Health now available.
https://t.co/M9kUr44Zwj https://t.co/LFPpnLMK4D
Links
Commercial claims analysis shows a significant association between acne and incident #IBD (OR 1.42; 1.23-1.65), but not
Tweet Content
Commercial claims analysis shows a significant association between acne and incident #IBD (OR 1.42; 1.23-1.65), but not with the drugs used to treat acne (tetracycline-class Abx or isotretinoin) https://t.co/VSHMRw4z7c https://t.co/S2o6Xw3Mfd
Links